• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Basel Medical Group Ltd

    5/16/25 9:25:04 AM ET
    $BMGL
    Medical/Nursing Services
    Health Care
    Get the next $BMGL alert in real time by email
    6-K 1 form6-k.htm 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

     

    Commission File Number: 001-42527

     

    Basel Medical Group Ltd

     

    6 Napier Road,

    Unit #02-10/11 Gleneagles Medical Centre

    Singapore 258499

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    Exhibit Index

     

    Exhibit No.   Description
    99.1   Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Basel Medical Group Ltd  
         
    By: /s/ Darren Yen Feng Chhoa  
    Name: Darren Yen Feng Chhoa  
    Title: Chief Executive Officer  
         
    Date: May 16, 2025  

     

     

     

     

    Get the next $BMGL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMGL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BMGL
    SEC Filings

    View All

    SEC Form 6-K filed by Basel Medical Group Ltd

    6-K - Basel Medical Group Ltd (0002004489) (Filer)

    12/1/25 5:00:26 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    SEC Form NT 20-F filed by Basel Medical Group Ltd

    NT 20-F - Basel Medical Group Ltd (0002004489) (Filer)

    10/27/25 4:05:14 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Basel Medical Group Ltd

    6-K - Basel Medical Group Ltd (0002004489) (Filer)

    8/21/25 6:30:03 AM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    $BMGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Receipt of Delinquency Notification from Nasdaq

    Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that the Company's annual report on Form 20-F for the fiscal year ended June 30, 2025 was incomplete and that the Company is delinquent in its filing obligations. This was because such report failed to include an opinion from the Company's auditor, NLA DFK Assurance PAC, on the Company's financial statements. Pursuant to Listing Rule 5250(c)(1), companies shall timely file all required periodic financial reports with the United States Securities and Exchange Commission, and annual reports filed shall contain audited financial stat

    12/1/25 4:30:00 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset

    Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of Bitcoin (BTC) holders have mutually agreed to pause the acquisition of digital asset. This decision reflects the ongoing regulatory review of digital assets by US authorities and the current lack of clarity on how forthcoming policies may impact the transaction. Given these uncertainties, both parties believe it is prudent to defer the deal until there is greater regulatory certainty. We will continue to monitor developments closely and reassess the opportunity once th

    7/17/25 4:30:00 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising

    Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company's initial public offering, has granted its consent on June 23, 2025 to the lock-up provision in the underwriting agreement dated February 24, 2025, permitting (i) a public offering or private placement of new securities of the Company, and (ii) the filing with the U.S. Securities and Exchange Commission of a registration statement under the Securities Act of 1933 in relation to such offering or placement, prior to the expiration of the lock-up period which was due to expire six mont

    6/26/25 4:15:00 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care